Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.665
-0.125 (-3.30%)
Oct 29, 2025, 3:19 PM EDT - Market open

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $836.00K in the quarter ending June 30, 2025, with 7.46% growth. This brings the company's revenue in the last twelve months to $2.94M, up 41.61% year-over-year. In the year 2024, Orchestra BioMed Holdings had annual revenue of $2.64M, down -4.42%.

Revenue (ttm)
$2.94M
Revenue Growth
+41.61%
P/S Ratio
49.03
Revenue / Employee
$42,057
Employees
70
Market Cap
197.75M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.64M-122.00K-4.42%
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings